Skip to main content
NCBI home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1979 Oct;67(2):161–164. doi: 10.1111/j.1476-5381.1979.tb08661.x

Naloxone reverses the antihypertensive effect of clonidine.

C Farsang, G Kunos
PMCID: PMC2043886  PMID: 227508

Abstract

In unanesthetized, spontaneously hypertensive rats the decrease in blood pressure and heart rate produced by intravenous clonidine, 5 to 20 micrograms/kg, was inhibited or reversed by nalozone, 0.2 to 2 mg/kg. The hypotensive effect of 100 mg/kg alpha-methyldopa was also partially reversed by naloxone. Naloxone alone did not affect either blood pressure or heart rate. In brain membranes from spontaneously hypertensive rats clonidine, 10(-8) to 10(-5) M, did not influence stereoselective binding of [3H]-naloxone (8 nM), and naloxone, 10(-8) to 10(-4) M, did not influence clonidine-suppressible binding of [3H]-dihydroergocryptine (1 nM). These findings indicate that in spontaneously hypertensive rats the effects of central alpha-adrenoceptor stimulation involve activation of opiate receptors. As naloxone and clonidine do not appear to interact with the same receptor site, the observed functional antagonism suggests the release of an endogenous opiate by clonidine or alpha-methyldopa and the possible role of the opiate in the central control of sympathetic tone.

Full text

PDF
161

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aghajanian G. K. Tolerance of locus coeruleus neurones to morphine and suppression of withdrawal response by clonidine. Nature. 1978 Nov 9;276(5684):186–188. doi: 10.1038/276186a0. [DOI] [PubMed] [Google Scholar]
  2. Arndt J. O., Freye E. Opiate antagonist reverses the cardiovascular effects of inhalation anaesthesia. Nature. 1979 Feb 1;277(5695):399–400. doi: 10.1038/277399a0. [DOI] [PubMed] [Google Scholar]
  3. Fielding S., Wilker J., Hynes M., Szewczak M., Novick W. J., Jr, Lal H. A comparison of clonidine with morphine for antinociceptive and antiwithdrawal actions. J Pharmacol Exp Ther. 1978 Dec;207(3):899–905. [PubMed] [Google Scholar]
  4. Finch L., Harvey C. A., Hicks P. E., Owen D. A. Clonidine-induced hypotension: further evidence for a central interaction with histamine H2 receptor antagonists in the rat. Neuropharmacology. 1978 Apr-May;17(4-5):307–313. doi: 10.1016/0028-3908(78)90116-8. [DOI] [PubMed] [Google Scholar]
  5. Geyskes G. G., Boer P., Dorhout Mees E. J. Clonidine withdrawal. Mechanism and frequency of rebound hypertension. Br J Clin Pharmacol. 1979 Jan;7(1):55–62. doi: 10.1111/j.1365-2125.1979.tb00897.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Gold M. S., Redmond D. E., Jr, Kleber H. D. Clonidine blocks acute opiate-withdrawal symptoms. Lancet. 1978 Sep 16;2(8090):599–602. doi: 10.1016/s0140-6736(78)92823-4. [DOI] [PubMed] [Google Scholar]
  7. Greenberg D. A., U'Prichard D. C., Sheehan P., Snyder S. H. alpha-Noradrenergic receptors in the brain: differential effects of sodium on binding of [3H]agonists and [3H]antagonists. Brain Res. 1978 Jan 27;140(2):378–384. doi: 10.1016/0006-8993(78)90472-9. [DOI] [PubMed] [Google Scholar]
  8. Holaday J. W., Faden A. I. Naloxone reversal of endotoxin hypotension suggests role of endorphins in shock. Nature. 1978 Oct 5;275(5679):450–451. doi: 10.1038/275450a0. [DOI] [PubMed] [Google Scholar]
  9. Jarrott B., Spector S. Disposition of clonidine in rats as determined by radioimmunoassay. J Pharmacol Exp Ther. 1978 Oct;207(1):195–202. [PubMed] [Google Scholar]
  10. Karppanen H., Paakkari I., Paakkari P., Huotari R., Orma A. L. Possible involvement of central histamine H2-receptors in the hypotensive effect of clonidine. Nature. 1976 Feb 19;259(5544):587–588. doi: 10.1038/259587a0. [DOI] [PubMed] [Google Scholar]
  11. Kobinger W., Walland A. Involvement of adrenergic receptors in central vagus activity. Eur J Pharmacol. 1971 Sep;16(1):120–122. doi: 10.1016/0014-2999(71)90066-5. [DOI] [PubMed] [Google Scholar]
  12. Kunos G., Hoffman B., Kwok Y. N., Kan W. H., Mucci L. Dihydroergocryptine binding and alpha-adrenoreceptors in smooth muscle. Nature. 1979 Mar 15;278(5701):254–256. doi: 10.1038/278254a0. [DOI] [PubMed] [Google Scholar]
  13. Laubie M., Schmitt H., Canellas J., Roquebert J., Demichel P. Centrally mediated bradycardia and hypotension induced by narcotic analgesics: dextromoramide and fentanyl. Eur J Pharmacol. 1974 Sep;28(1):66–75. doi: 10.1016/0014-2999(74)90113-7. [DOI] [PubMed] [Google Scholar]
  14. Laubie M., Schmitt H., Vincent M., Remond G. Central cardiovascular effects of morphinomimetic peptides in dogs. Eur J Pharmacol. 1977 Nov 1;46(1):67–71. doi: 10.1016/0014-2999(77)90146-7. [DOI] [PubMed] [Google Scholar]
  15. Pert C. B., Snyder S. H. Properties of opiate-receptor binding in rat brain. Proc Natl Acad Sci U S A. 1973 Aug;70(8):2243–2247. doi: 10.1073/pnas.70.8.2243. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Schmitt H., Boissier J. R., Giudicelli J. F. Centrally mediated decrease in sympathetic tone induced by 2(2,6-dichlorophenylamino)-2 imidazoline (S.T. 155, Catapresan). Eur J Pharmacol. 1967 Nov;2(2):147–148. doi: 10.1016/0014-2999(67)90041-6. [DOI] [PubMed] [Google Scholar]
  17. Schmitt H., Fenard S. Evidence for an alpha-sympathomimetic component in the effects of catapresan on vasomotor centres: antagonism by piperoxane. Eur J Pharmacol. 1971;14(1):98–100. doi: 10.1016/0014-2999(71)90130-0. [DOI] [PubMed] [Google Scholar]
  18. Srimal R. C., Gulati K., Dhawan B. N. On the mechanism of central hypotensive action of clonidine. Can J Physiol Pharmacol. 1977 Oct;55(5):1007–1014. doi: 10.1139/y77-138. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES